Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pleural Effusion, Malignant × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Lymphoma, Non-Hodgkin 9 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Neoplasms 4 Melanoma 4 Lymphoma, B-Cell 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Arthritis, Rheumatoid 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia 2 Hematologic Neoplasms 2 Fallopian Tube Neoplasms 2 Cytokine Release Syndrome 2 Craniopharyngioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 COVID-19 2

Interventions

Cisplatin 8 Carboplatin 7 Bevacizumab 7 Talc 6 Paclitaxel 5 Pleurodesis 4 Doxycycline 4 Docetaxel 4 Taxes 3 Gemcitabine 3 Zoledronic Acid 2 Trastuzumab 2 Thoracoscopy 2 Sodium Chloride 2 Silver Nitrate 2 Povidone-Iodine 2 Nivolumab 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chest Tubes 2 Bortezomib 2 viscum album peptide 1 tocilizumab 1 tipifarnib 1 talimogene laherparepvec 1 romidepsin 1 rilotumumab 1 lipoplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡